Welcome to our dedicated news page for NeueHealth (Ticker: BHG), a resource for investors and traders seeking the latest updates and insights on NeueHealth.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NeueHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NeueHealth's position in the market.
Rhea-AI Summary
NeueHealth, Inc. (NYSE: NEUE) will release its First Quarter 2024 financial results on May 8, 2024, followed by a conference call at 8:00 AM Eastern Time. Participants can join via telephone or webcast. Pre-registration is required for telephone participation. The earnings call will be accessible on NeueHealth's Investor Relations page.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.05%
Tags
-
Rhea-AI Summary
NeueHealth, Inc. (NEUE) announced an incremental amendment to its credit facility with NEA, increasing the term loan commitment by $30 million. The proceeds will be used for general corporate purposes and to support the company's 2024 strategic priorities. NeueHealth will issue penny warrants to purchase up to 1,113,563 shares of common stock to lenders under the facility. The Audit Committee approved the omission to seek shareholder approval due to financial viability concerns. The NYSE has approved the company's reliance on an exception under its Listed Company Manual.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.57%
Tags
-
Rhea-AI Summary
NeueHealth, Inc. reported strong full-year 2023 results, with revenue reaching $1.2 billion and serving 461,000 consumers. The company expects Enterprise Adjusted EBITDA between $15 million and $25 million for 2024. Despite a net loss in 2023, NeueHealth is confident in its value-driven care model and aims for continued growth in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.13%
Tags
Rhea-AI Summary
NeueHealth, Inc. (NEUE) will report Fourth Quarter financial results on March 6, 2024, with a conference call at 8:00 AM Eastern Time. Participants can join via telephone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Bright Health Group, Inc. announced that it has adopted NeueHealth as its corporate brand name, reflecting the Company’s ongoing focus on its NeueHealth business. The Company's common stock will begin trading under the new ticker symbol “NEUE” on the New York Stock Exchange (NYSE) on January 29, 2024. NeueHealth currently serves more than 500,000 health consumers and partners with more than 3,000 affiliated providers across the country. The Company will also relocate its corporate headquarters from Minneapolis to Doral, Florida.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
-
Rhea-AI Summary
Bright Health Group, Inc. (NYSE: BHG) completes final repayment on secured credit facility, focuses on increasing access to value-driven healthcare, and reaffirms expectation for Adjusted EBITDA profitability in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.91%
Tags
Rhea-AI Summary
Company XYZ (XYZ) Receives Regulatory Approvals for Sale of California Medicare Advantage Business
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
45.06%
Tags
-
Rhea-AI Summary
Medical Home Network (MHN) provider partners achieved $10.1 million in gross savings and a 100% quality score in the 2022 performance year under the ACO Realizing Equity, Access, and Community Health (REACH) Model, including 20 FQHCs across Ohio, Missouri, and Illinois. MHN is a leading care enablement partner for safety net providers, and its provider partners participating in the NeueHealth (NYSE: BHG) ACO worked together to transform care for patients and excel in value-based care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.16%
Tags
-
Rhea-AI Summary
Bright Health Group, Inc. reported a Q3’23 Revenue from Continuing Business of $269.4 million, up 39% year over year, with a Net Loss from Continuing Business of $479.3 million. The company is maintaining its expectation for 2023 consolidated Adjusted EBITDA profitability. Bright Health expects to close the sale of its California Medicare Advantage business to Molina Healthcare by the First Quarter of 2024. The company is providing updated 2023 financial outlook with Revenue forecasts for the Care Solutions segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
Rhea-AI Summary
Bright Health Group, Inc. will report Third Quarter financial results on November 7, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.68%
Tags
NeueHealth, Inc.
NYSE:BHG
BHG Rankings
BHG Stock Data
130.81M
3.36M
4.93%
65.03%
1.31%
Direct Life Insurance Carriers
Finance and Insurance
United States
Minneapolis
About BHG
bright health delivers a smarter, more connected healthcare experience. the company’s affordable health insurance plans, exclusive partnerships with leading health systems, and simple, friendly approach to technology are reshaping how people and physicians achieve better health together. today, bright health provides health insurance to individuals in colorado and will be expanding to other geographies and product offerings in 2018. we are united by a common vision: to deliver the best healthcare experience by putting brilliant minds, empathetic hearts and personalized technology to work to create meaningful relationships between our members and care partners. our mission: making healthcare right. together.